Researchers use iPS cells to produce liver cells

04/5/2010 | Mainichi Daily News (Tokyo)

Japanese researchers were able to turn induced pluripotent stem cells into high purity liver tissue through the introduction of two types of genes. The researchers said the produced liver tissue was comparable to natural tissue, which can process toxins. The synthetic tissue has the potential to be used in screening experimental drugs' toxicity levels.

View Full Article in:

Mainichi Daily News (Tokyo)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC